Where our team of guest writers discuss what they think about the current NGP US Issues.
Lowering operating costs and improving the quality of drug discovery and development is on top of the pharmaceutical company’s agenda. Labcyte’s acoustic droplet ejection can help.
Has lab-on-a-chip design become pounding your assay design to fit existing structures or can you get a biochip that is your assay design as you developed it? By Stephen F. Malin, CFD Research Corporation
The use of new technologies to overcome many of the initial challenges in microRNA research will allow comprehensive studies of microRNA expression patterns and identification of microRNA biomarkers in cancer and other diseases over the next few year
With William Janzen, President & COO at Amphora Discovery
Corporation